US 11291663
Methods of treating cancer with farnesyltransferase inhibitors
granted A61KA61K31/4704A61K31/4709
Quick answer
US patent 11291663 (Methods of treating cancer with farnesyltransferase inhibitors) held by Kura Oncology, Inc. expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/4704, A61K31/4709, A61P, A61P35/02